Company Overview - Aflac (AFL) is expected to report quarterly earnings of $1.68 per share, reflecting a year-over-year increase of +1.2% [3] - Revenues are anticipated to be $4.38 billion, which represents a decline of 19.5% compared to the same quarter last year [3] Earnings Expectations - The earnings report is scheduled for release on April 30, 2025, and could influence stock movement based on whether the results exceed or fall short of expectations [2] - The consensus EPS estimate has been revised 0.99% higher in the last 30 days, indicating a slight positive sentiment among analysts [4] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that Aflac has a negative Earnings ESP of -0.65%, suggesting a bearish outlook from analysts [10][11] - Aflac currently holds a Zacks Rank of 3 (Hold), complicating predictions of an earnings beat [11] Historical Performance - In the last reported quarter, Aflac was expected to earn $1.62 per share but only achieved $1.56, resulting in a surprise of -3.70% [12] - Over the past four quarters, Aflac has beaten consensus EPS estimates three times [13] Industry Context - Another player in the insurance sector, Unum (UNM), is expected to report earnings of $2.19 per share, reflecting a year-over-year increase of +3.3% [17] - Unum's revenues are projected to be $3.33 billion, up 4.1% from the previous year [17] - Unum has a negative Earnings ESP of -0.58% and a Zacks Rank of 4 (Sell), indicating challenges in predicting an earnings beat [18]

Core Insights - The Aflac Wellness Matters Survey highlights that 90% of Americans delay preventive checkups or screenings, with younger generations particularly affected by various barriers [1][2][3] Group 1: Preventive Care Challenges - 94% of Americans face barriers to obtaining recommended screenings in a timely manner [2] - Common screenings avoided include pap smears (33%), prostate exams (32%), colonoscopies (32%), mammograms (31%), blood tests (31%), full body skin cancer exams (27%), and STD screenings (22%) [3] - Millennials (62%) and Gen Z (61%) are the most likely to avoid these screenings [3] Group 2: Attitudes Towards Health Care - 65% of Americans become proactive about their health only after experiencing a health scare [4] - Those who believe they will be diagnosed with cancer are more likely to delay screenings (62% vs. 42%) [4] Group 3: Primary Care Access - Nearly 20% of Americans lack a regular primary care physician, often citing good health as the reason [7] - 41% of Americans, particularly Gen Z (51%) and millennials (54%), primarily use urgent care or emergency rooms for medical needs [7] Group 4: Generational Differences - Younger generations are more likely to consult family and friends or social media for health concerns, with 68% interested in using AI for health issues [8][9] - Gen Z women (68%) are more likely to skip screenings compared to Gen Z men (55%) [10] Group 5: Influence of Community and Family - 70% of individuals confident in their loved ones' health priorities are more likely to prioritize their own health [12] - 24% of those diagnosed with cancer were urged by a loved one to get checked, indicating the importance of social support in health care decisions [13][14] Group 6: Aflac's Role and Commitment - Aflac emphasizes the importance of preventive care and the establishment of trusted relationships with primary care physicians [6][15] - The company has been recognized for its ethical practices and commitment to corporate social responsibility [17][18]

COLUMBUS, Ga., April 3, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter 2025 financial results after the market closes on April 30, 2025. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer Max Brodén, on the company's Investor Relations website, investors.aflac.com.Aflac Incorporated wi ...

Core Investment Insights - Investing in dividend-paying stocks is a strategy for building long-term wealth, as these companies often have strong business models and prudent capital management [1] - Over five decades, dividend-paying stocks have delivered an average annual return of 9.17%, significantly outperforming non-dividend payers at 4.27% [2] - Companies that initiate or grow their dividends have returned even better, with an average return of 10.19% [2] Company Analysis: Chubb - Chubb operates in 54 countries, providing a wide range of insurance products including property and casualty, personal accident, and life insurance [4] - Berkshire Hathaway has invested in Chubb, purchasing 27 million shares, making it the ninth-largest holding in Berkshire's U.S. stock portfolio [5] - Chubb's combined ratio has averaged 90.6% over the past 22 years, well below the industry average of 99.7%, indicating strong underwriting ability [8] - The company recently approved a 6.5% increase in its dividend, marking the 32nd consecutive year of dividend growth [8] Company Analysis: Aflac - Aflac offers life and supplemental insurance plans, facing challenges during low interest rates and the COVID-19 pandemic [9][10][11] - The stock has increased by 85% since 2022 due to improving claims costs and rising interest rates [11] - Aflac raised its dividend payout by 16%, extending its 42-year history of dividend growth [12] Company Analysis: Cincinnati Financial - Cincinnati Financial has a strong history of rewarding investors and solid underwriting performance [14] - The company grew its earned premiums by 12% to $8.9 billion last year, with investment income increasing by 15% to $1 billion [15] - Cincinnati Financial announced a 7.4% increase in its dividend payout, achieving a 65-year streak of annual payout increases [15]

The Zacks Accident and Health Insurance industry is expected to benefit from an increase in underwriting exposure. Aflac Incorporated (AFL) , Unum Group (UNM) , Trupanion (TRUP) , Employers Holdings, Inc. (EIG) and AMERISAFE, Inc. (AMSF) are expected to be driven by prudent underwriting standards. However, higher inflation, as well as rising medical costs, could offset the positives. The industry has been witnessing soft pricing over the past several quarters, and this is not expected to change any time soo ...

Group 1 - The article discusses companies that have the potential to achieve Dividend King status, indicating a focus on long-term dividend growth and sustainability [1] - The author has a strong academic background in Analytics and Accounting, along with over 10 years of experience in the investment field, which adds credibility to the analysis [1] - Dividend investing is highlighted as a personal interest of the author, suggesting a passion for identifying companies with reliable dividend payouts [1] Group 2 - There is no mention of any stock, option, or derivative positions held by the author in the companies discussed, indicating an unbiased perspective [2] - The article does not provide specific investment recommendations or advice, emphasizing that past performance does not guarantee future results [3] - The author expresses personal opinions, which may not reflect the views of the broader Seeking Alpha community, highlighting the individual nature of the analysis [3]

As a part of the campaign, TOGETHXR and Aflac generated an interactive digital map that serves as a guiding resource of bar destinations across the country, where women's sports fans can watch tournament action. The digital map will be available at TOGETHXR.com and will be visible through featured posts on the @TOGETHXR and @GETTOGETHXR Instagram accounts. "TOGETHXR is proud to continue our partnership with Aflac, united in our commitment to create spaces where everyone can come together to celebrate women' ...

Only insurance company in the world to be on this list since its inception in 2007COLUMBUS, Ga., March 11, 2025 /PRNewswire/ -- Aflac Incorporated, a leading provider of health supplemental insurance in the U.S. and the leading provider of cancer and medical insurance in terms of policies in force in Japan, was once again named by Ethisphere as one of the World's Most Ethical Companies, marking 2025 as the 19th consecutive year on this esteemed list. This year, 136 honorees were recognized spanning 19 count ...

COLUMBUS, Ga., Feb. 27, 2025 /PRNewswire/ -- Aflac, the leading provider of supplemental health insurance in the U.S.,1 today announced the hiring of Michael Fradkin as senior vice president, Aflac Dental and Vision, a business unit that is a key component of the company's offering. Fradkin will report to Aflac U.S. Executive Vice President, COO and CFO Frederic Simard and will lead operations with a focus on customer experience, provider network growth and business expansion. 30 year industry veteran Mi ...

Business Performance - Total revenues for 2024 increased by 1.2% to $18.9 billion, compared to $18.7 billion in 2023[204]. - Net earnings for 2024 were $5.4 billion, or $9.63 per diluted share, up from $4.7 billion, or $7.78 per diluted share in 2023[204]. - Net investment gains in 2024 were $1.3 billion, compared to $590 million in 2023, including $1.1 billion from derivatives and foreign currency gains[205]. - Adjusted earnings for 2024 were $4.1 billion, or $7.21 per diluted share, compared to $3.7 billion, or $6.23 per diluted share in 2023[206]. - Shareholders' equity at December 31, 2024, was $26.1 billion, or $47.45 per share, up from $22.0 billion, or $38.00 per share in 2023[207]. - The company repurchased $2.8 billion worth of common shares, totaling 30.4 million shares in 2024[206]. - The annualized return on average shareholders' equity in 2024 was 22.6%[207]. Product Offerings - Aflac Japan launched a new cancer insurance product, WINGS, in August 2022, and a cancer consultation support service in January 2023, enhancing its offerings[31]. - In September 2023, Aflac Japan introduced a new medical insurance product targeting younger policyholders[32]. - Aflac U.S. offers a range of insurance products including accident, disability, critical illness, and hospital indemnity insurance, catering to both individual and group markets[50][51][52][53]. Distribution and Sales - Aflac Japan's distribution network includes approximately 6,600 sales agencies and 114,000 licensed sales associates as of the end of 2024[38]. - Aflac U.S. sales force included an average of approximately 6,000 agents actively producing business weekly in 2024[58]. - Approximately half of total new annualized premium sales for Aflac U.S. group business are generated in the fourth quarter, resulting in over one third of total sales occurring in that period[55]. - The company is expanding its distribution strategy to directly reach consumers outside of traditional worksites through digital lead generation[58]. - Aflac Japan has agreements with approximately 90% of banks in Japan to sell its insurance products[42]. - The Company has agreements with 360 banks in Japan, with sales through these banks representing 3% of Aflac Japan's new annualized premium sales in 2024[140]. Financial Risks and Market Conditions - Aflac Japan's solvency margin ratio (SMR) is sensitive to interest rate, credit spread, and foreign exchange rate changes, with measures in place to mitigate these sensitivities[45]. - The Company faces risks from high inflation and economic uncertainty, which could adversely affect its investments and profitability[94]. - A sustained decline in interest rates could hinder the Company's ability to earn the returns assumed in the pricing and reserving for its insurance products[108]. - A rise in interest rates would improve the Company's ability to earn higher rates of return on future investments, but could also negatively impact the fair values of fixed maturity investments[109]. - The Company is exposed to significant interest rate risk, which may adversely affect its results of operations, financial condition, and liquidity[106]. - Fluctuations in the yen/dollar exchange rate can significantly affect the Company's reported financial position and results of operations[122]. Regulatory and Compliance - The company is subject to state regulations that require fair and equitable transactions within its insurance holding company system[61]. - Aflac U.S. is monitoring emerging legislation and regulations to ensure compliance with privacy and cybersecurity requirements[71]. - The Company is subject to extensive regulation, and changes in laws could materially impact profitability and growth[166]. - Failure to meet minimum capital requirements by subsidiaries could lead to regulatory actions and affect the Company's financial strength ratings[168]. Employee Engagement and Diversity - Aflac Japan's employee engagement survey results are reported to the Human Capital Management Policy Committee to identify issues and implement improvements[89]. - In 2024, 60% of new hires in the U.S. were people of color and 69% were women, reflecting the company's commitment to diversity[90]. - Aflac Japan's Heartful Services promotes the hiring of employees with disabilities, with 119 out of 153 employees having a disability as of December 31, 2024[90]. - Aflac U.S. offers various internships and educational opportunities to enhance employee skills and career development[84]. - The company has implemented a human capital management system to help employees proactively design their careers[83]. - Aflac Japan launched the Aflac Leadership Academy in 2024 to develop next-generation management[83]. Technology and Innovation - The company is investing in technology and product innovation, including artificial intelligence, to enhance customer experience and operational efficiency[147]. - The company is heavily reliant on its telecommunication and information technology systems, which are subject to risks such as cyberattacks and data breaches that could adversely affect its financial condition[148]. - The company maintains a global information security program to protect its data and that of its customers from cybersecurity threats[179]. Competitive Landscape - The company operates in a competitive environment, facing potential competition from both existing and new companies, which could adversely affect its market share and profitability[169]. - The company has seen increased competition as major medical carriers seek entry into Aflac's supplemental product segments[60]. - Aflac U.S. competes against several supplemental insurance carriers, believing its policies and premium rates are competitive by product type[59]. Risk Management - The Company's risk management framework may not effectively identify or mitigate emerging risks, potentially leading to unexpected losses[154]. - The company faces operational risks from third-party vendors, which could disrupt business operations and negatively impact revenues and reputation[159]. - Compliance with privacy and information security regulations is critical, as violations could result in significant fines and damage to the Company's reputation[162]. Economic and Environmental Factors - Catastrophic events, including climate change and public health issues, could significantly impact the company's financial condition and operational results[171]. - The company has a global crisis management framework to minimize business disruption from catastrophic events, but its effectiveness is uncertain[172]. Accounting and Financial Reporting - Changes in accounting standards could materially affect the company's financial statements and results of operations[175]. - The assumptions used in establishing premiums and reserves are inherently uncertain, and deviations from these assumptions could materially affect the Company's financial results[146].